Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03694678 · ClinicalTrials.gov registry record · NA

Building Resiliency in Patients Admitted to the Neuroscience Intensive Care Unit and Their Caregivers

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
126
Enrollment target

NCT03694678: Completed NA study, sponsored by Massachusetts General Hospital.

NCT03694678 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03694678, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
126 participants
Enrollment target

Study Summary

The investigators will compare a dyadic intervention (Recovering Together) with an attention placebo educational control in dyads of patients with acute neurological illnesses and their caregivers at risk for chronic emotional distress. The primary aim of this study is to determine the feasibility, credibility, and satisfaction with Recovering Together. The second aim is to show proof of concept for sustained improvement in emotional distress, post traumatic stress (PTS), resiliency and interpersonal communication outcomes in patients and caregivers.

Interventions

  • BEHAVIORAL Recovering Together

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2019-01-01
Est. Completion 2020-10-11
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03694678

The ClinicalTrials.gov registry entry for NCT03694678 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Recovering Together is the first listed.

NCT03694678 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03694678 about?

NCT03694678 is a clinical study titled "Building Resiliency in Patients Admitted to the Neuroscience Intensive Care Unit and Their Caregivers". The investigators will compare a dyadic intervention (Recovering Together) with an attention placebo educational control in dyads of patients with acute neurological illnesses and their caregivers at risk for chronic emotional distress. The primary aim of this study is to determine the feasibility, ...

What is the current status of trial NCT03694678?

This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2019-01-01. Estimated completion is 2020-10-11.

What interventions are being tested in trial NCT03694678?

The interventions under investigation include: Recovering Together (BEHAVIORAL).

Who is sponsoring clinical trial NCT03694678?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.